Published in J Antibiot (Tokyo) on November 01, 1972
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin. Antimicrob Agents Chemother (1974) 2.50
Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. Antimicrob Agents Chemother (1976) 2.12
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents. Antimicrob Agents Chemother (1981) 1.38
Rosamicin--a new drug for the treatment of bacterial prostatitis. Antimicrob Agents Chemother (1977) 1.37
In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains. Antimicrob Agents Chemother (1977) 1.36
Regulation of a macrolide resistance-beta-galactosidase (ermC-lacZ) gene fusion in Escherichia coli. J Bacteriol (1984) 0.96
High-pressure liquid chromatographic method for determination of rosaramicin in humans. Antimicrob Agents Chemother (1980) 0.90
Evaluation of rosaramicin phosphate in treatment of experimental syphilis in rabbits. Antimicrob Agents Chemother (1981) 0.90
Pharmacokinetics and metabolism of rosaramicin in humans. Antimicrob Agents Chemother (1984) 0.84
Levantilides A and B, 20-membered macrolides from a Micromonospora strain isolated from the Mediterranean deep sea sediment. Mar Drugs (2011) 0.80
In vitro comparison of rosamicin and erythromycin against urinary tract pathogens. Antimicrob Agents Chemother (1979) 0.80
Pharmacokinetics and metabolism of [14C]rosaramicin in dogs. Antimicrob Agents Chemother (1986) 0.75
Susceptibility of skin and throat strains of group A streptococci to rosamicin and erythromycin. Antimicrob Agents Chemother (1978) 0.75
In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli. Antimicrob Agents Chemother (1978) 0.75
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med (1982) 4.05
Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin. Antimicrob Agents Chemother (1972) 3.32
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother (1976) 3.26
A new Micromonospora-produced macrolide antibiotic, rosamicin. J Antibiot (Tokyo) (1972) 3.12
Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic. J Antibiot (Tokyo) (1970) 3.01
Recent microbiological studies with gentamicin. J Infect Dis (1969) 2.65
Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic. J Antibiot (Tokyo) (1970) 2.59
Induction of resistance to bacterial infections of mice with poly I-poly C. Nature (1970) 2.40
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother (2000) 2.33
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Binding of aminoglycosides to feces. Antimicrob Agents Chemother (1974) 2.17
Accuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis. BJOG (2012) 2.14
Microbiologic studies related to bacterial resistance to gentamicin. J Infect Dis (1971) 1.91
A virulent nosocomial Klebsiella with a transferable R factor for gentamicin: emergence and suppression. J Infect Dis (1971) 1.73
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Antimicrob Agents Chemother (1978) 1.61
Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion (1995) 1.54
Mutamicins; biosynthetically created new sisomicin analogues. J Antibiot (Tokyo) (1974) 1.53
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51
Antibiotic G-418, a new Micromonospora-produced aminoglycoside with activity against protozoa and helminths: fermentation, isolation, and preliminary characterization. Antimicrob Agents Chemother (1974) 1.38
Considerations of pool size in the manufacture of plasma derivatives. Transfusion (1996) 1.38
Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med (1980) 1.32
Antibiotic G418, a new micrommomospora-produced aminglycoside with activity apainst protozoa and helminths: antiparasitic activity. Antimicrob Agents Chemother (1975) 1.29
Renal pharmacology of netilmicin. Antimicrob Agents Chemother (1977) 1.29
Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole). Appl Microbiol (1971) 1.26
Aspects of the chronic toxicity of gentamicin sulfate in cats. J Infect Dis (1971) 1.23
Comparison of enzymatic and microbiological gentamicin assays. Antimicrob Agents Chemother (1974) 1.20
Biological aspects of the interaction between gentamicin and carbenicillin. J Antibiot (Tokyo) (1972) 1.19
Biological activity of the antibiotic components of the gentamicin complex. J Bacteriol (1967) 1.15
Binding of aminoglycoside antibiotics to filtration materials. Antimicrob Agents Chemother (1975) 1.15
Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B. J Antibiot (Tokyo) (1978) 1.13
Halomicin, a new Micromonospora-produced antibiotic. Antimicrob Agents Chemother (Bethesda) (1967) 1.13
Biological activity of Sch 14342, an aminoglycoside antibiotic coproduced in the gentamicin fermentation. Antimicrob Agents Chemother (1972) 1.12
Relations among antimalarial drugs: results of studies with cycloguanil-, sulfone-, or chloroquine-resistant Plasmodium berghei in mice. Am J Trop Med Hyg (1967) 1.12
Chromatographic separation of the components of the gentamicin complex. J Chromatogr (1968) 1.12
Differential specificities of the thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors. Biochim Biophys Acta (1972) 1.09
Neomycin production by Micromonospora species 69-683. J Antibiot (Tokyo) (1973) 1.09
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304. Antimicrob Agents Chemother (1992) 1.08
Antibiotic from Micromonospora. Annu Rev Microbiol (1980) 1.06
Laboratory studies on the joint effects of certain tris (p-aminophenyl) carbonium salts and antimonials as antischistosomal drugs. Bull World Health Organ (1965) 1.03
Biological activity of antibiotic G-418, a new micromonospora-produced aminoglycoside with activity against protozoa and helminths. Antimicrob Agents Chemother (1974) 1.01
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice. Antimicrob Agents Chemother (1992) 1.00
Gentamicin antibiotics. 4. Some condensation products of gentamicin C2 with aromatic and aliphatic aldehydes. J Med Chem (1971) 0.99
Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med (1986) 0.99
Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells. J Antibiot (Tokyo) (1978) 0.99
Kijanimicin (Sch 25663), a novel antibiotic produced by Actinomadura kijaniata SCC 1256. Fermentation, isolation, characterization and biological properties. J Antibiot (Tokyo) (1981) 0.98
Modulation of influenza in mice by transfer factor therapy. J Reticuloendothel Soc (1978) 0.94
Purification and biological studies of everninomicin B. Antimicrob Agents Chemother (Bethesda) (1965) 0.93
Evaluation of the in-vitro activity of Sch 29482. J Antimicrob Chemother (1982) 0.91
'Prophylactic' activity of tolnaftate in experimental Trichophyton mentagrophytes infections of guinea pigs. Chemotherapy (1969) 0.88
Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood (1984) 0.88
Biological activity of megalomicin, a new Micromonospora-produced macrolide antibiotic complex. J Antibiot (Tokyo) (1969) 0.88
Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc (1995) 0.87
Quantitative determination of factor-VIII protein by two-stage gel electrophoresis. Br J Haematol (1976) 0.87
The hazimicins, a new class of antibiotics. Taxonomy, fermentation, isolation, characterization and biological properties. J Antibiot (Tokyo) (1983) 0.86
Renal uptake and nephrotoxicity of gentamicin during urinary alkalinization in rats. Clin Exp Pharmacol Physiol (1979) 0.85
Verdamicin, a new broad spectrum aminoglycoside antibiotic. Antimicrob Agents Chemother (1975) 0.85
Physiological disposition of antimony after administration of 124Sb-labelled tartar emetic to rats, mice and monkeys, and the effects of tris (p-aminophenyl) Carbonium pamoate on this distribution. Bull World Health Organ (1965) 0.84
Hepatic- and celiac-artery aneurysms. JAMA (1966) 0.84
Megalomicin, a new macrolide antibiotic complex produced by Micromonospora. J Antibiot (Tokyo) (1969) 0.84
Sch 29482, a new penem antibiotic: evaluation of in-vitro activity and effect of test conditions. J Antimicrob Chemother (1982) 0.83
The biosynthesis of hazimicins: possible origin of isonitrile carbon. J Antibiot (Tokyo) (1985) 0.83
Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). J Am Vet Med Assoc (1992) 0.83
A new broad spectrum aminoglycoside antibiotic, G-52, produced by Micromonospora zionensis. J Antibiot (Tokyo) (1976) 0.82
Effects of paromomycin on tapeworms of mice, rats, and cats. J Parasitol (1966) 0.82
Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. J Clin Invest (1984) 0.81
New polyene antifungal antibiotic produced by a species of Actinoplanes. Antimicrob Agents Chemother (1975) 0.81
Comparative in vitro and in vivo antifungal activity of tolnaftate and various undecylenates. J Pharm Sci (1980) 0.81
Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen. Blood (1983) 0.80